Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Clinical Neurology and Neurosurgery
|
June 1, 1999
Prothrombin gene variant (G20210A) in a patient with cerebral venous sinus thrombosis
J van Krimpen, F W Leebeek, D W Dippel, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1989
Histidine-rich glycoprotein is elevated in mild liver cirrhosis and decreased in moderate and severe liver cirrhosis
F W Leebeek, C Kluft, E A Knot, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
November 24, 1999
[Portal vein thrombosis: causes and treatment]
H L Janssen, H R van Buuren, F W Leebeek, et al.
The Netherlands Journal of Medicine
|
April 1, 1995
Rhabdomyolysis associated with influenza A virus infection
F W Leebeek, M G Baggen, L J Mulder, et al.
American Journal of Hematology
|
January 1, 1989
Severe thrombotic tendency associated with a type I plasminogen deficiency
F W Leebeek, E A Knot, J W Ten Cate, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 28, 2016
Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study: reply
J S Biedermann, A M van den Besselaar, F W Leebeek, et al.
Thrombosis and Haemostasis
|
February 25, 1988
Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiency
F W Leebeek, J Stibbe, E A Knot, et al.
Gastroenterology
|
November 1, 1991
A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis
F W Leebeek, C Kluft, E A Knot, et al.
British Journal of Haematology
|
September 12, 1998
Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis
F W Leebeek, J S Lameris, H R van Buuren, et al.
Journal of the American College of Cardiology
|
May 1, 1990
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin
F W Leebeek, C Kluft, E A Knot, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Clinical Neurology and Neurosurgery
|
June 1, 1999
Prothrombin gene variant (G20210A) in a patient with cerebral venous sinus thrombosis
J van Krimpen, F W Leebeek, D W Dippel, et al.
The Journal of Laboratory and Clinical Medicine
|
April 1, 1989
Histidine-rich glycoprotein is elevated in mild liver cirrhosis and decreased in moderate and severe liver cirrhosis
F W Leebeek, C Kluft, E A Knot, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
November 24, 1999
[Portal vein thrombosis: causes and treatment]
H L Janssen, H R van Buuren, F W Leebeek, et al.
The Netherlands Journal of Medicine
|
April 1, 1995
Rhabdomyolysis associated with influenza A virus infection
F W Leebeek, M G Baggen, L J Mulder, et al.
American Journal of Hematology
|
January 1, 1989
Severe thrombotic tendency associated with a type I plasminogen deficiency
F W Leebeek, E A Knot, J W Ten Cate, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 28, 2016
Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study: reply
J S Biedermann, A M van den Besselaar, F W Leebeek, et al.
Thrombosis and Haemostasis
|
February 25, 1988
Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiency
F W Leebeek, J Stibbe, E A Knot, et al.
Gastroenterology
|
November 1, 1991
A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis
F W Leebeek, C Kluft, E A Knot, et al.
British Journal of Haematology
|
September 12, 1998
Budd-Chiari syndrome, portal vein and mesenteric vein thrombosis in a patient homozygous for factor V Leiden mutation treated by TIPS and thrombolysis
F W Leebeek, J S Lameris, H R van Buuren, et al.
Journal of the American College of Cardiology
|
May 1, 1990
Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin
F W Leebeek, C Kluft, E A Knot, et al.
Page
of 3